Article Details

Genentech takes over Regor's RGT-419B for US$850m upfront - European Biotechnology

Retrieved on: 2024-10-01 17:12:20

Tags for this article:

Click the tags to see associated articles and topics

Genentech takes over Regor's RGT-419B for US$850m upfront - European Biotechnology. View article details on hiswai:

Excerpt

Genentech, the US subsidiary of Swiss pharmaceutical giant Roche AG, has strengthened the company's breast cancer pipeline by pre-licensing the ...

Article found on: european-biotechnology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up